检索结果-南通市图书馆

The miRna let-7al inhibits the expression of insulin-like growth factor 1 receptor （IGFIR） in prostate cancer PC-3 cells

引用

Asian Journal of Andrology 2013年第6期15卷 753-758,I0006页

作者： li-na wang wei-wen chen ju zhang chao-yang li chun-yan liu iing xue peng-ju zhang an-li jiang Institution of Biochemistry and Molecular Biology Medical School of Shandong University Jinan 250012 China

Reduced microRna （miRna） let-7a expression and the activation of insulin-like growth factor-1 receptor （IGFIR） signalling are both involved in prostate cancer and progression. In the present study, we demonstrated that the growth inhibitory effect of let-7al is directly related to targeting IGFIRgene expression in PC-3 cells. TargetScan predicted three potential target sites （T1, T2 and T3） of let-7a in the 3＇ untranslational region （3＇ UTR） of IGFIR mRna. Real-time PCR, Western blot and luciferase reporter assays were used to detect the effects of let-7al overexpression or let-7al inhibitor on the IGFIRgene expression in PC-3 cells. The results indicated that let-7al could inhibit IGFIR expression by directly targeting the T1 and T2 sites in the 3＇ UTR of the IGFIR mRna. We then used RT-PCR, luciferase reporter assays, 3-（4,5-dimethylthiazol-2-yl）-2,5-diphenyl-2H-tetrazolium bromide （MTT） assay, flow cytometry and Hoechst 33342 staining to examine whether let-7al-mediated inhibition of IGFIR expression also affects the IGFIR-mediated signalling events, including Elk1 activity and c-fos gene expression, proliferation, apoptosis and cell cycle. We demonstrated that let-7al-mediated IGFIR downregulation was accompanied by attenuation of Elk1 activity and c-fos expression, inhibition of cell proliferation, enhanced apoptosis and cell cycle arrest, and that loss function of let-7al via inhibition can upregulate IGF1R accompanied by an increase of Elk1 activity and c-fos expression, thereby enhancing cell proliferation. Altogether, these findings sueeest that let-7a mav be novel therapeutic candidate for Drostate cancer.

关键词： IGFIR microRna (miRna) prostate cancer

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Timing analysis of the black hole candidate EXO 1846–031 with Insight-HXMT monitoring

引用

Research in Astronomy and Astrophysics 2021年第3期21卷 193-204页

作者： He-Xin liu Yue Huang Guang-cheng Xiao Qing-Cui Bu Jin-Lu Qu Shu zhang Shuang-nan zhang Shu-Mei Jia Fang-jun Lu Xiang Ma lian Tao wei zhang li chen li-Ming Song Ti-Pei li Yu-peng Xu xue-Lei Cao Yong chen Cong-Zhan liu Ce Cai Zhi Chang Gang chen Tian-Xiang chen Yi-Bao chen Yu-peng chen wei Cui wei-wei Cui Jing-Kang Deng Yong-wei Dong Yuan-Yuan Du Min-xue Fu Guan-Hua Gao He Gao Min Gao Ming-Yu Ge Yu-Dong Gu ju Guan cheng-cheng Guo Da-wei Han Jia Huo Lu-Hua jiang wei-chun jiang Jing Jin Yong-Jie Jin ling-Da Kong Bing li cheng-Kui li Gang li Mao-Shun li wei li Xian li Xiao-Bo li Xu-Fang li yang-Guo li Zheng-wei li Xiao-Hua liang Jing-Yuan liao Bai-Sheng liu Guo-Qing liu Hong-wei liu Xiao-Jing liu Yi-Nong liu Bo Lu xue-Feng Lu Qi Luo Tao Luo Bin Meng Yi nang Jian-Yin Nie Ge Ou na Sai Ren-cheng Shang Xin-Ying Song liang Sun Ying Tan You-li Tuo chen wang Guo-Feng wang juan wang ling-jun wang weng-Shuai wang Yu-Sa wang Xiang-yang wen Bai-yang Wu Bo-Bing Wu Mei Wu Shuo Xiao Shao-lin Xiong He Xu Jia-wei yang Sheng yang yan-Ji yang Yi-jung yang Qi-Bin Yi Qian-Qing Yin Yuan You Ai-Mei zhang cheng-Mo zhang Fan zhang Hong-Mei zhang juan zhang Tong zhang Wan-Chang zhang wen-Zhao zhang Yi zhang Yi-Fei zhang Yong-Jie zhang Yuan-Hang zhang Yue zhang Zhao zhang Zhi zhang Zi-liang zhang Hai-Sheng Zhao Xiao-Fan Zhao Shi-Jie Zheng Yao-Guang Zheng Deng-Ke Zhou Jian-Feng Zhou Yu-Xuan Zhu Ren-lin Zhuang Yue Zhu Key Laboratory of Particle Astrophysics Institute of High Energy PhysicsChinese Academy of SciencesBeijing 100049China University of Chinese Academy of Sciences Chinese Academy of SciencesBeijing 100049China Institut fur Astronomie und Astrophysik Kepler Center for Astro and Particle PhysicsEberhard Karls Universität72076 TubingenGermany Department of Astronomy Beijing Normal UniversityBeijing 100088China Department of Astronomy Tsinghua UniversityBeijing 100084China Department of Physics Tsinghua UniversityBeijing 100084China Department of Engineering Physics Tsinghua UniversityBeijing 100084China Key Laboratory of Space Astronomy and Technology National Astronomical ObservatoriesChinese Academy of SciencesBeijing 100101China College of Physics Sciences&Technology Hebei UniversityBaoding 071002Hebei ProvinceChina

We present the observational results from a detailed timing analysis of the black hole candidate EXO 1846-031 during its outburst in 2019 with the observations of Insight-HXMT,NICER and *** outburst can be classified roughly into four different ***-C quasi-periodic oscillations(QPOs)observed by NICER(about 0.1-6 Hz)and Insight-HXMT(about 0.7-8 Hz)are also reported in this ***,we study various physical quantities related to QPO *** QPO rms-frequency relationship in the energy band 1-10 keV indicates that there is a turning pointing in frequency around2 Hz,which is similar to that of GRS 1915+105.A possible hypothesis for the relationship above may be related to the inclination of the source,which may require a high inclination to explain *** relationships between QPO frequency and QPO rms,hardness,total fractional rms and count rate have also been found in other transient sources,which can indicate that the origin of type-C QPOs is non-thermal.

关键词： X-ray binaries black hole candidate QPO EXO 1846–031

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline(updated version)

引用

Military Medical Research 2020年第3期7卷 249-282页

作者： Ying-Hui Jin Qing-Yuan Zhan Zhi-Yong peng xue-Qun Ren Xun-Tao Yin lin Cai Yu-Feng Yuan Ji-Rong Yue Xiao-chun zhang Qi-wen yang jianguang Ji Jian Xia Yi-Rong li Fu-Xiang Zhou Ya-Dong Gao Zhui Yu Feng Xu Ming-li Tu li-Ming Tan Min yang Fang chen Xiao-ju zhang Mei Zeng Yu Zhu Xin-Can liu Jian yang Dong-Chi Zhao Yu-Feng Ding Ning Hou Fu-Bing wang Hao chen Yong-Gang zhang wei li wen chen Yue-Xian Shi Xiu-Zhi yang xue-jun wang yan-jun Zhong Ming-juan Zhao Bing-Hui li lin-Lu Ma Hao Zi na wang Yun-Yun wang Shao-Fu Yu Lu-Yao li Qiao Huang Hong weng Xiang-Ying Ren li-Sha Luo Man-Ru Fan Di Huang Hong-yang xue lin-Xin Yu Jin-Ping Gao Tong Deng Xian-Tao Zeng Hong-jun li Zhen-Shun cheng Xiao-Mei Yao Xing-Huan wang Center for Evidence-Based and Translational Medicine Zhongnan Hospital of Wuhan UniversityWuhan 430071China national Clinical Research Center for Respiratory Diseases China-Japan Friendship HospitalBeijing 100029China Department of Pulmonary and Critical Care Medicine China-Japan Friendship HospitalBeijing 10029China Leishenshan Hospital in Wuhan Wuhan 430200China Department of Critical Care Medicine Zhongnan Hospital of Wuhan UniversityWuhan 430071China Institutes of Evidence-based Medicine and Knowledge Translation Henan UniversityKaifeng 475000HenanChina Department of Medical Imaging Guizhou Provincial People’s HospitalGuiyang 550002China Departments of Orthopedics Zhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Hepatobiliary Surgery Zhongnan Hospital of Wuhan UniversityWuhan 430071China national Clinical Research Center for Geriatrics West China Hospital of Sichuan UniversityChengdu 610041China Department of Geriatrics West China Hospital of Sichuan UniversityChengdu 610041China Department of Radiology Zhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Clinical Laboratory Peking Union Medical College Hospital(PUMCH)Peking Union Medical CollegeChinese Academy of Medical Sciences(CAMS)Beijing 100730China Center for Primary Health Care Research Lund University and Region Skåne25002 MalmöSweden Emergency Center Zhongnan Hospital of Wuhan UniversityWuhan 403371China Department of Allergology Zhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Radiation and Medical Oncology Zhongnan Hospital of Wuhan UniversityWuhan 43071China Department of Critical Care Medicine Renmin Hospital of Wuhan UniversityWuhan 430060China Department of Emergency Medicine and Chest Pain Center Qilu Hospital of Shandong UniversityJinan 250002China Department of Respiratory and Critical Care Medicine Suizhou Central HospitalHubei University of MedicineSuizhou 441300HubeiChina Department of Clinic Pharmacy Second People’s Hospital of Huaihua Ci

The novel severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)is the cause of a rapidly spreading illness,coronavirus disease 2019(COVID-19),affecting more than seventeen million people around the *** and treatment guidelines for clinicians caring for patients are *** the early stage,we have issued"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus(2019-nCoV)infected pneumonia(standard version)";now there are many direct evidences emerged and may change some of previous recommendations and it is ripe for develop an evidence-based *** formed a working group of clinical experts and *** steering group members proposed 29 questions that are relevant to the management of COVID-19 covering the following areas:chemoprophylaxis,diagnosis,treatments,and discharge *** searched the literature for direct evidence on the management of COVID-19,and assessed its certainty generated recommendations using the Grading of Recommendations,Assessment,Development and Evaluation(GRADE)*** were either strong or weak,or in the form of ungraded consensus-based ***,we issued 34 *** them,6 were strong recommendations for,14 were weak recommendations for,3 were weak recommendations against and 11 were ungraded consensus-based *** covered topics of chemoprophylaxis(including agents and Traditional Chinese Medicine(TCM)agents),diagnosis(including clinical manifestations,reverse transcription-polymerase chain reaction(RT-PCR),respiratory tract specimens,IgM and IgG antibody tests,chest computed tomography,chest X-ray,and CT features of asymptomatic infections),treatments(including lopinavirritonavir,umifenovir,favipiravir,interferon,remdesivir,combination of antiviral drugs,hydroxychloroquine/chloroquine,interleukin-6 inhibitors,interleukin-1 inhibitors,glucocorticoid,qingfei paidu decoction,lianhua qingwen granules/capsules,convalescent plasma,lung

关键词： COVID-19 SARS-CoV-2 Recommendation Chemoprophylaxis Diagnosis Treatment Discharge management Traditional Chinese medicine guideline

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Who can benefit more from its twelve-week treatment:A prospective cohort study of blonanserin for patients with schizophrenia

引用

World Journal of Psychiatry 2024年第11期14卷 1735-1745页

作者： Bao-yan Xu Kun Jin Hai-Shan Wu xue-jun liu Xi-Jin wang Hong Sang Ke-Qing li Mei-juan Sun Hua-Qing Meng Huai-li Deng Zhi-Yuan Xun Xiao-Dong yang lin zhang Guan-jun li Rui-ling zhang Duan-Fang Cai Jia-Hong liu Gui-jun Zhao Long-Fa liu Gang wang Chang-lie Zhao Bin Guo Sheng-chun Jin ling-Yun Huang Fu-De yang Jian-Min Zheng Gui-Lai Zhan Mao-Sheng Fang Xiang-jun Meng Guang-Ya zhang Hai-Min li Xiang-Lai liu ju-Hong li Bin Wu Hai-Yun li Jin-Dong chen Department of Psychiatry National Clinical Research Center for Mental DisordersNational Center for Mental DisordersThe Second Xiangya Hospital of Central South UniversityChangsha 410011Hunan ProvinceChina Department of Psychiatry Hebei Provincial Mental Health CenterHebei Key Laboratory of Major Mental and Behavioral DisordersThe Sixth Clinical Medical College of Hebei UniversityBaoding 071000Hebei ProvinceChina Department of Psychiatry Brain Hospital of Hunan ProvinceChangsha 410000Hunan ProvinceChina Department of Psychiatry The First Psychiatric Hospital of HarbinHarbin 150000Heilongjiang ProvinceChina Mental Health Center Changchun Sixth HospitalChangchun 130000Jilin ProvinceChina Department of Pharmacy Daqing Third HospitalDaqing 163000Heilongjiang ProvinceChina Department of Physical and Psychological Rehabilitation Guangda Rehabilitation HospitalChongqing 400000China Department of Psychology Shanxi Provincial Mental Health CenterTaiyuan 030000Shanxi ProvinceChina Department of Psychiatry Tianjin Anding HospitalTianjin 300000China Department of Psychiatry Shandong Mental Health CenterJinan 250000Shandong ProvinceChina Department of Psychiatry Fuzhou Shenkang HospitalFuzhou 350000Fujian ProvinceChina Department of Psychiatry Shanghai Mental Health CenterShanghai Jiao Tong University School of MedicineShanghai 200000China Department of Psychiatry The Second Affiliated Hospital of Xinxiang Medical UniversityXinxiang 453000Henan ProvinceChina Department of Psychiatry The Fifth People’s Hospital of ZigongZigong 643000Sichuan ProvinceChina Department of Psychiatry The Affiliated Kangning Hospital of Wenzhou Medical UniversityWenzhou 325000Zhejiang ProvinceChina Department of Psychiatry Guangyuan Mental Health CenterGuangyuan 628000Sichuan ProvinceChina Department of Psychiatry Jilin Sixth People’s HospitalJilin 132000Jilin ProvinceChina The national Clinical Research Center for Mental Disorders&Beijing Key Laboratory of Mental Disorders Beijing Anding Hospital

BACKGROUND Blonanserin(BNS)is a well-tolerated and effective drug for treating *** To investigate which types of patients would obtain the most benefit from BNS *** A total of 3306 participants were evaluated in a 12-week,prospective,multicenter,open-label post-marketing surveillance study of *** psychiatric rating scale(BPRS)scores were calculated to evaluate the effectiveness of BNS,and its safety was assessed with the incidence of adverse drug *** regression was used to screen the influencing factors for the reduction of BPRS total score,and logistic regression was used to identify patients with a better response to *** The baseline BPRS total score(48.8±15.03)decreased to 27.7±10.08 at 12 weeks(Pline BPRS total score,current episode duration,number of previous episodes,dose of concomitant antipsychotics,and number of types of sedative-hypnotic agents were found to be independent factors affecting the reduction of BPRS total score after treatment ***,patients in the acute phase with baseline BPRS total score≥45,current episode duration<3 months,and≤3 previous episodes derived greater benefit from 12-week treatment with *** Patients in the acute phase with more severe symptoms,shorter current episode duration,fewer previous episodes,and a lower psychotropic drug load derived the greatest benefit from treatment with BNS.

关键词： Schizophrenia Blonanserin Effectiveness Psychosocial functioning Prospective cohort study

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Searching for ^(76)Ge neutrinoless double beta decay with the CDEX-1B experiment

引用

Chinese Physics C 2024年第10期48卷 11-22页

作者： Bing-Tao zhang jun-Zheng wang li-Tao yang Qian Yue Ke-jun Kang Yuan-Jing li Hai-peng An C.Greeshma Jian-Ping Chang Yun-Huan chen Jian-Ping cheng wen-Han Dai Zhi Deng Chang-Hao Fang Xin-Ping Geng Hui Gong Qiu-ju Guo Xu-Yuan Guo li He Sheng-Ming He Jin-wei Hu Han-Xiong Huang Tu-chen Huang Hai-Tao Jia Xi jiang S.Karmakar Hao-Bin li Jian-Min li Jin li Qian-Yun li Ren-Ming-Jie li xue-Qian li Yu-Lan li Yi-Fan liang Bin liao Fong-Kay lin Shin-Ted lin Jia-Xuan liu Shu-Kui liu yan-Dong liu Yu liu Yuan-Yuan liu Zhong-Zhi liu Hao Ma Yu-Cai Mao Qi-Yuan Nie Jin-Hua Ning Hui Pan Ning-chun Qi Jie Ren Xi-chao Ruan Ze She Manoj Kumar Singh Tian-Xi Sun Chang-Jian Tang wei-You Tang yang Tian Guang-Fu wang li wang Qing wang Yu-Feng wang Yun-Xiang wang Henry-Tsz-King Wong Shi-Yong Wu Yu-cheng Wu Hao-yang Xing Rui Xu Yin Xu Tao xue Yu-Lu yan nan Yi chun-Xu Yu Hai-jun Yu Jian-Feng Yue Ming Zeng Zhi Zeng Feng-Shou zhang Lei zhang Zhen-Hua zhang Zhen-Yu zhang Kang-Kang Zhao Ming-Gang Zhao Ji-Fang Zhou Zu-Ying Zhou Jing-jun Zhou Key Laboratory of Particle and Radiation Imaging(Ministry of Education)and Department of Engineering Physics Tsinghua UniversityBeijing 100084 Department of Physics Tsinghua UniversityBeijing 100084 Institute of Physics Academia SinicaTaipei 11529 NUCTECH Company Beijing 100084 YaLong River Hydropower Development Company Chengdu 610051 College of Nuclear Science and Technology Beijing Normal UniversityBeijing 100875 College of Physics Sichuan UniversityChengdu 610065 School of Physics Peking UniversityBeijing 100871 Department of Nuclear Physics China Institute of Atomic EnergyBeijing 102413 Sino-French Institute of Nuclear and Technology Sun Yat-sen UniversityZhuhai 519082 School of Physics Nankai UniversityTianjin 300071 Department of Physics Banaras Hindu UniversityVaranasi 221005 Department of Physics Beijing Normal UniversityBeijing 100875

We operated a p-type point contact high purity germanium(PPCGe)detector(CDEX-1B,1.008 kg)in the China Jinping Underground Laboratory(CJPL)for 500.3 days to search for neutrinoless double beta(0νββ)decay of ^(76)Ge.A total of 504.3 kg⋅day effective exposure data was *** anti-coincidence and the multi/single-site event(MSE/SSE)discrimination methods were used to suppress the background in the energy region of interest(ROI,1989–2089 keV for this work)with a factor of 23.A background level of 0.33 counts/(keV⋅kg⋅yr)was *** lower limit on the half life of^(76)Ge 0νββdecay was constrained as T_(1/2)^(0ν)>1.0×10^(23)yr(90%C.L.),corresponding to the upper limits on the effective Majorana neutrino mass:<3.2–7.5 eV.

关键词： neutrinoless double beta decay CDEX point-contact germanium detector ^(76)Ge

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Prevalence, awareness, treatment, and control of hypertension in the non-dialysis chronic kidney disease patients

引用

Chinese Medical Journal 2013年第12期126卷 2276-2280页

作者： ZHENG Ying CAI Guang-yan chen Xiang-mei FU Ping chen jiang-hua DING Xiao-qiang YU xue-qing liN Hong-li liu Jian XIE Ru-juan wang li-ning NI Zhao-hui liu Fu-you YIN Ai-ping XING Chang-ying wang li SHI wei liu Jian-she HE Ya-ni DING Guo-hua li wen-ge WU Guang-li MIAO li-ning chen nan SU Zhen MEI Chang-lin ZHAO Jiu-yang GU Yong BAI Yun-kai LUO Hui-min liN Shan chen Meng-hua GONG li yang Yi-bin yang Xiao-ping li Ying WAN Jian-xin wang Nian-song li Hai-ying XI chun-sheng HAO li XU yan FANG Jing-ai liu Bi-cheng li Rong-shan wang Rong zhang Jing-hong wang Jian-qin LOU Tan-qi SHAO Feng-min MEI Feng liu Zhi-hong YUAN wei-jie SUN Shi-ren zhang ling ZHOU chun-hua chen Qin-kai JIA Shun-lian GONG Zhi-feng GUAN Guang-ju XIA Tian ZHONG liang-bao Department of Nephrology State key Laboratory of Kidney Disease Chinese PLA General Hospital Beijing 100853 China Nephrology Institute of the Chinese People's liberation Army Chinese People's Liberation Army Key Laboratory of Nephrology Beijing 100853 China Department of Nephrology West China Hospital of Sichuan University Chengdu Sichuan 610041 China Department of Nephrology First Affiliated Hospital School of Medicine Zhejiang University Hangzhou Zhejiang 310003 China Department of Nephrology Zhongshan Hospital Fudan University Shanghai 200032 China Department of Nephrology First Affiiated Hospital of Sun Yat-sen University Guangzhou Guangdong 510080 China Department of Nephrology First Affiliated Hospital of Dalian Medical University Dalian Liaoning 116011 China Department of Nephrology First Affiliated Hospital of Xinjiang Medical University Urumqi Xinjiang 830054 China Department of Nephrology First Affiliated Hospital of Harbin Medical University Harbin Heilongjiang 150001 China Department of Nephrology First Afftiated Hospital of China Medical University Shenyang Liaoning 110001 China Department of Nephrology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200025 China Department of Nephrology Second Xiangya Hospital Central South University Changsha Hunan 410000 China Department of Nephrology First Affiliated Hospital of Medical College Xi'an Jiaotong University Xi'an Shaanxi 710061 China Department of Nephrology First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital) Nanjing Jiangsu 210029 China Department of Nephrology Sichuan Provincial People's Hospital Chengdu Sichuan 610072 China Department of Nephrology Guangdong Provincial People's Hospital Guangzhou Guangdong 510030 China Department of Nephrology Affliated Xiehe Hospital Tongji Medical College Huazhong Science and Technology University Wuhan Hubei 430022 China Department of Nephrology Daping Hospital Third Military Medi

Background Data on the epidemiology of hypertension in Chinese non-dialysis chronic kidney disease （CKD） patients are *** aim of the present study was to investigate the prevalence,awareness,treatment,and control of hypertension in the non-dialysis CKD patients through a nationwide,multicenter study in *** The survey was performed in 61 tertiary hospitals in 31 provinces,municipalities,and autonomous regions in China （except Hong Kong,Macao,and Taiwan）.Trained physicians collected demographic and clinical data and measured blood pressure （BP） using a standardized *** was defned as systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg,and/or use of antihypertensive *** 〈140/90 mmHg and 〈130/80 mmHg were used as the 2 thresholds of hypertension *** multivariate logistic regression with adjustment for sex and age,we analyzed the association between CKD stages and uncontrolled hypertension in non-dialysis CKD *** The analysis included 8927 non-dialysis CKD *** prevalence,awareness,and treatment of hypertension in non-dialysis CKD patients were 67.3%,85.8%,and 81.0%,*** hypertensive CKD patients,33.1% and 14.1% had controlled BP to 〈140/90 mmHg and 〈130/80 mmHg,*** successive CKD stages,the prevalence of hypertension in non-dialysis CKD patients increased,but the control of hypertension decreased （P〈0.001）.When the threshold of BP 〈130/80 mmHg was considered,the risk of uncontrolled hypertension in CKD 2,3a,3b,4,and 5 stages increased 1.3,1.4,1.4,2.5,and 4.0 times compared with CKD 1 stage,respectively （P〈0.05）.Using the threshold of 〈140/90 mmHg,the risk of uncontrolled hypertension increased in advanced stages （P〈0.05）.Conclusions The prevalence of hypertension Chinese non-dialysis CKD patients was high,and the hypertension control was *** successive CKD stages,the risk of uncontrolled hypertension increased.

关键词： non-dialysis chronic kidney disease chronic kidney disease stages hypertension epidemiology

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Consensus statement on layout and delivery of automatic external defibrillator in China

引用

Journal of Hainan Medical University 2020年第15期26卷 18-23页

作者： Yu Cao Song chen yan-Fen Chai Xiao-Hui chen Yu-Guo chen Shao-wen cheng wen-wei cheng Bang-Han Ding yang Deng Jie Fu Bang-jiang Fang Mai-Ying Fan li Gui Ping Gong wei Guo Shu-Bin Guo liang Huang Ji-Yuan Han Zhong Ji Xian-Fei Ji Xin-Cai Ji Hong-Xu Jin Xin-jun jiang wang-Xiang jiang Jia-liang liu Xiao-Ran liu Zhi liu Chuan-Zhu Lv Feng Lu Tan-Shi li Xin li Yong li Shang-Lun li Shuang-Ming li Xiao-Gang li Bao-jun li Pei-Wu li chun-Sheng li Zhi-jun li Chang-Luo li Xiang-Min li Yin-Ping li Zong-jun Lu Zu-Xun Lu Zhong-Qiu Lu Zhi-Qian Luo Xiao-Xing liao Jian-Bo Lei Tao Ma Yu Ma Yue-Feng Ma Qing-Bian Ma lin-Hao Ma jun-Qi Ma Shi-nan Nie Jie-Miao Ou-yang peng peng Qiao Pei Shu-Ming Pan Guo-Zhong Qing li-Jie Qin Wu-Ying Qiao Fei Shao wei Song Xing-Yue Song Zhen-ju Song Rong-ju Sun De-Ya Shang Du-juan Sha Gui-Lan Tao Guo-Gang Tian Ying-Ping Tian Jian-Guang Tian chao-yang Tong Zi-Ren Tang Meng-Xiong Tang Guo-Ping Wu Zhi Wan Tao wang Xin wang peng wang Zhong wang Tong wang Ri-Xing wang Yi-Xin wang Xiao-Dan wang ling Wu wei wei Hua Xiang Feng Xu jun Xu Jie Xu Miao-Rong Xie Shuo-Gui Xu Tie Xu Feng Yu wen Yi li-Shan yang Shi-Jiao yan Jin-Jian Yao Shou-chun yan xue-Zhong Yu Xian-Zhi Ye Xian-liang yan Fu-Bing Zhou Rong-Bin Zhou Ming Zhou Qiang Zhou Jin Zhou Ping Zhou Chang-ju Zhu Hua-Dong Zhu Ji-Hong Zhu Hong zhang Mao zhang Hua zhang na zhang Guo-Qiang zhang Guo-Xiu zhang Jin-Song zhang wen-Wu zhang wen-Zhong zhang Jian-Feng zhang Yi-Min Zhu jun Zeng Yuan Zheng Zhi-Jie Zheng Shen Zhao yan Zhao Min Zhao Bin Zhao Xiao-Dong Zhao Xiao-Jing Zhao Hong-Ke Zeng Sheng-Qiang Zou The Chinese Society of Emergency Medicine Research Unit of Island Emergency Medicine Chinese Academy of Medical SciencesHainan Medical University Key Laboratory of Emergency and Trauma of Ministry of Education Hainan Medical UniversityHaikouHainanChina Emergency and Trauma College Hainan Medical UniversityHaikouHainanChina Department of Emergency Hainan Clinical Research Center for Acute and Critical DiseasesThe Second Affiliated Hospital of Hainan Medical UniversityHaikouHainanChina Key Laboratory of Hainan Trauma and Disaster Rescue Key Laboratory of Trauma of Hainan Medical University

*** Sudden cardiac death(SCD)refers to sudden death due to a variety of cardiac *** is manifested as a sudden loss of consciousness,cardiac arrest,and respiratory arrest and generally shows early symptoms that are atypical and not easily detected[1].According to a recent study,nearly 544000 patients suffer from SCD every year in China[2].

关键词： cardiac death respiratory

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

新型冠状病毒肺炎药物预防、诊断、治疗与出院管理循证临床实践指南(更新版)

引用

解放军医学杂志 2020年第10期45卷 1003-1031页

作者：靳英辉詹庆元彭志勇任学群尹训涛蔡林袁玉峰岳冀蓉张笑春杨启文纪建光夏剑李一荣周福祥高亚东余追徐峰涂明利谭力铭杨旻陈芳张晓菊曾玫朱渝刘新灿杨简赵东赤丁玉峰侯宁汪付兵陈昊张永刚李玮陈文施月仙杨秀芝王学军钟燕军赵明娟李柄辉马琳璐訾豪王娜王云云余绍福李路遥黄桥翁鸿任相颖罗丽莎范曼如黄笛薛竑飏余临心高锦萍邓通曾宪涛李宏军程真顺姚晓梅王行环无武汉大学中南医院循证与转化医学中心武汉430071 中日友好医院国家呼吸系统疾病临床研究中心北京100029 中日友好医院呼吸与危重症医学科北京100029 武汉雷神山医院武汉430200 武汉大学中南医院重症医学科武汉430071 河南大学循证医学与临床转化研究院河南开封475000 贵州省人民医院医学影像科贵阳550002 武汉大学中南医院骨科武汉430071 武汉大学中南医院肝胆外科武汉430071 四川大学华西医院国家老年疾病临床医学研究中心成都610041 四川大学华西医院老年医学中心成都610041 武汉大学中南医院医学影像中心武汉430071 中国医学科学院/北京协和医学院检验学系北京协和医院检验科北京100730 瑞典隆德大学临床研究中心/斯科讷大学医院马尔默25002 武汉大学中南医院急救中心武汉403371 武汉大学中南医院过敏反应科武汉403371 武汉大学中南医院肿瘤放化疗科武汉403371 武汉大学人民医院重症医学科武汉430060 山东大学齐鲁医院急诊科与胸痛中心济南250002 湖北医药学院附属随州市中心医院呼吸与重症医学科湖北随州441300 湖南省怀化市第二人民医院药学部湖南怀化418000 安徽医科大学第二附属医院重症医学科合肥230601 郑州大学医院内科郑州450001 河南省人民医院呼吸与危重症医学科郑州450003 复旦大学附属儿科医院感染传染科上海201102 四川大学华西第二医院感染科成都610041 河南中医药大学第一附属医院心内科郑州450000 三峡大学人民医院/宜昌市第一人民医院心内科湖北宜昌443000 武汉大学中南医院儿科武汉430071 华中科技大学同济医学院附属同济医院药学部武汉430030 山东第一医科大学附属省立医院/山东省立医院药学部济南250021 南京中医药大学教育部针药结合重点实验室南京210023 四川大学华西医院华西期刊社成都610041 青岛大学附属烟台毓璜顶医院检验医学中心山东烟台264000 十堰市太和医院(湖北医药学院附属医院)医学影像中心湖北十堰442000 北京大学护理学院北京100191 开封市中心医院呼吸与危重症医学科河南开封475000 北京电力医院急诊科北京100073 中南大学湘雅二医院重症医学科长沙410008 武汉大学中南医院泌尿科武汉430071 武汉大学中南医院血液科武汉430071 河南大学医学院护理与健康学院河南开封475000 山西医科大学护理学院太原030001 首都医科大学北京佑安医院放射诊断科北京100069 武汉大学中南医院呼吸与危重症医学科武汉430071 麦克马斯特大学卫生研究方法证据及影响系安大略省哈密尔顿市L8S 4L8加拿大中国医疗保健国际交流促进会循证医学分会中国研究型医院学会

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)导致的新型冠状病毒肺炎(COVID-19)自暴发以来迅速在全球蔓延,造成数以千万人感染及数十万患者死亡。基于研究证据的临床实践指南是诊治COVID-19的有力武器。在疫情早期阶段,该团队制定并发布... 详细信息

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)导致的新型冠状病毒肺炎(COVID-19)自暴发以来迅速在全球蔓延,造成数以千万人感染及数十万患者死亡。基于研究证据的临床实践指南是诊治COVID-19的有力武器。在疫情早期阶段,该团队制定并发布了《新型冠状病毒(2019-nCoV)感染的肺炎诊疗快速建议指南(标准版)》。疫情暴发后大量相关临床研究陆续开展并发表,新的证据可能会改变以前的推荐意见,更新指南的时机已经成熟。因此,该团队成立了由临床专家和方法学家组成的工作组,通过咨询一线临床专家提出并确定了与COVID-19管理相关的29个临床问题。通过系统检索有关COVID-19预防及诊疗的直接证据,使用GRADE方法评估证据质量并制订推荐意见,最终形成34条建议,其中6条强推荐,14条弱推荐,3条弱不推荐,11条为基于共识的建议;共涵盖4个方面,分别为药物预防,诊断(包括临床表现、RT-PCR检测、呼吸道标本、IgM和IgG抗体检测、CT检查、胸部X线片及无症状感染的CT特征),治疗方法[包括洛匹那韦-利托那韦、阿比朵尔、法匹拉韦、干扰素、瑞德西韦、抗病毒药的组合、羟氯喹/氯喹、白介素-6抑制剂、白介素-1抑制剂、糖皮质激素、清肺排毒汤、连花清瘟胶囊/颗粒、康复者血浆、肺移植、有创或无创通气、体外膜肺氧合支持(ECMO)]以及出院管理(包括复阳患者管理及出院标准)。此外,还制订了针对推荐意见的指南实施工具流程图,以期有力支持医护人员对COVID-19患者的照护。

关键词：新型冠状病毒肺炎 2019新型冠状病毒感染性疾病临床实践指南循证医学

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

鸡痘鹌鹑化弱毒活疫苗生产工艺改进试验

引用

中国兽药杂志 2005年第9期39卷 46-47页

作者：齐琳韩明香齐铁英李宝臣南锡王莉娟刘春菊王春伟王雪菲张艳红王芳孟庆春张亚华东北农业大学生命科学院黑龙江哈尔滨150001 黑龙江省生物制品一厂黑龙江哈尔滨150046 农业部动物检疫所国家动物疫病诊断液制备中心山东青岛266032

采用人工气室绒毛尿囊膜和尿囊腔两种接种方法制备鸡痘活疫苗,结果表明经尿囊腔接种的结果和经人工气室绒毛尿囊膜接种的结果相同。因此,以尿囊腔接种代替人工气室绒毛尿囊膜接种,可以降低成本,简化工艺。本试验为以后采用机械化接种生... 详细信息

采用人工气室绒毛尿囊膜和尿囊腔两种接种方法制备鸡痘活疫苗,结果表明经尿囊腔接种的结果和经人工气室绒毛尿囊膜接种的结果相同。因此,以尿囊腔接种代替人工气室绒毛尿囊膜接种,可以降低成本,简化工艺。本试验为以后采用机械化接种生产鸡痘苗提供了可靠的数据。

关键词：鸡痘鹌鹑化弱毒人工气室绒毛尿囊膜尿囊腔

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

中国13家医院住院分娩早产儿呼吸窘迫综合征前瞻性调查分析

引用

发育医学电子杂志 2016年第2期4卷 106-118页

作者：徐凤丹段顺艳孔祥永封志纯张珊吴鸿雁吕红艳杨李红吴素静巨容汪瑾彭立李占魁赵小林曾淑娟丘惠娴温伟溪武辉李莹李楠贾文峥张雪峰郭果刘卫鹏王凤李改梅刘芳李薇赵晓英程红斌许云波陈文超尹欢丁艳洁王晓亮单瑞艳陈铁强许平韩梅盈杨春燕广东医科大学广东东莞523808 北京军区总医院附属八一儿童医院新生儿科北京100700 邯郸市妇幼保健院新生儿科河北邯郸056001 成都市妇女儿童中心医院新生儿科成都610091 陕西省妇幼保健院新生儿科西安710061 深圳市龙岗中心医院新生儿科广东深圳518116 吉林大学第一医院新生儿科长春130021 中国人民解放军第三〇二医院新生儿科北京100039 中国人民解放军海军总医院新生儿科北京100048 白求恩国际和平医院新生儿科石家庄050082 黄石市妇幼保健院新生儿科湖北黄石435003 烟台毓璜顶医院新生儿科山东烟台264000 长沙市妇幼保健院新生儿科长沙410007 聊城市人民医院新生儿科山东聊城252000

目的了解国内住院分娩早产儿呼吸窘迫综合征（respiratory distress syndrome,RDS）的发生率、病死率、并发症特点、发生高危因素、产前激素应用对早产儿RDS的发生率及预后的影响。方法收集国内13家医院2014年1月1日至12月31日住院分娩... 详细信息

目的了解国内住院分娩早产儿呼吸窘迫综合征（respiratory distress syndrome,RDS）的发生率、病死率、并发症特点、发生高危因素、产前激素应用对早产儿RDS的发生率及预后的影响。方法收集国内13家医院2014年1月1日至12月31日住院分娩的24周≤胎龄〈37周的全部早产儿共7684例。前瞻性分析RDS发生率、病死率、并发症、发生高危因素及产前应用地塞米松的效果。结果活产出生新生儿共75 360例,其中早产儿7 684例（其中入院早产儿6604例,非入院1080例）,早产儿发生率为10.2%。其中极早产儿957例,占12.5%;超早产儿92例,占1.2%。发生RDS 1 177例,发生率为15.3%。24周≤胎龄〈25周、25周≤胎龄〈26周、26周≤胎龄〈27周、27周≤胎龄〈28周、28周≤胎龄〈29周、29周≤胎龄〈30周、30周≤胎龄〈31周、31周≤胎龄〈32周、32周≤胎龄〈33周、33周≤胎龄〈34周、34周≤胎龄〈35周、35周≤胎龄〈36周、36周≤胎龄〈37周早产儿RDS发生率分别为100.0%、90.0%、85.0%、85.1%、81.0%、74.3%、55.4%、47.1%、33.1%、17.9%、9.6%、5.0%、1.9%。出生体重〈500 g、500~749 g、750~999 g、1 000~1 499 g、1 500~2 499 g、2 500~4 000 g、〉4 000 g早产儿RDS的发生率分别为100.0%、100.0%、79.2%、55.8%、15.0%、3.6%、9.5%。RDS早产儿病死率为10.5%,其中胎龄24周≤胎龄〈25周、25周≤胎龄〈26周、26周≤胎龄〈27周、27周≤胎龄〈28周、28周≤胎龄〈29周、29周≤胎龄〈30周、30周≤胎龄〈31周、31周≤胎龄〈32周、32周≤胎龄〈33周、33周≤胎龄〈34周、34周≤胎龄〈35周、35周≤胎龄〈36周、36周≤胎龄〈37周早产儿RDS病死率,分别为100%、70.0%、23.5%、20.0%、16.2%、10.3%、8.1%、9.6%、8.9%、6.0%、5.5%、8.8%、4.5%。RDS患儿颅内出血（ICH）、早产儿视网膜病（ROP）、支气管肺发育不良（BPD）、坏死性小肠结肠炎（NEC）、动脉导管未闭（PDA）、肺出血及败血症的发生率较非RDS早产儿高,差异有非常显著性（P〈0.001）。logistic回归分析显示：男性、胎龄〈33周、出生体重〈2 500 g、身长〈40 cm、新生儿窒息、产次≥2次、前置胎盘是早产儿RDS发病的危险因素;多胎妊娠是RDS的保护因素。胎龄〈33周早产儿RDS发病高危因素包括：男性、胎龄〈28周、出生体重〈2 500 g、身长〈40 cm、新生儿窒息、前置胎盘;产前应用地塞米松是RDS的保护因素。胎龄≥33周早产儿RDS发病高危因素包括：男性、胎龄〈35周、出生体重〈2 500 g、新生儿窒息、产次≥2次、剖宫产、前置胎盘;多胎妊娠是RDS的保护因素。产前应用地塞米松2 879例,占37.5%。胎龄〈33周地塞米松组RDS发生率较非地塞米松组低。地塞米松组胎龄〈33周RDS发生率、重度RDS发生率、病死率均较非地塞米松组低,差异有显著性;地塞米松组需要使用2剂以上肺表面活性物质的比例、机械通气比例、机械通气时间均较非地塞米松组低,差异无显著性;地塞米松组总吸氧时间较非地塞米松组高,差异无显著性;地塞米松组总住院时间较非地塞米松组长,差异有显著性。地塞米松组胎龄≥33周早产儿,除RDS发生率、重度RDS发生率、机械通气比例、总吸氧时间、总住院时间较非地塞米松组高且差异有显著性外,余差异均无显著性。结论国内早产儿发生率较前上升,早产儿及极早产儿、超早产儿救治存活率均较前明显提高。RDS患儿病死率及并发症发生率较高。胎龄〈33周的早产儿RDS的发病高危因素多为自身因素,产前应用地塞米松能有效减少RDS的发生率并改善预后;胎龄≥33周的早产儿RDS发病高危因素则多为围产期病理因素,产前地塞米松预防RDS的作用不明显。

关键词：早产儿呼吸窘迫综合征产前激素前瞻性调查分析

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：